This reduction could lead to loss of the negative regulatory function of PTPN2 and PTPN22. Furthermore, this decrease in PTPN2/22 expression in edited Jurkat T-cells was at a markedly greater reduction than our lab’s previous findings using clinical blood samples from CD and RA patients. The gene discussed is PTPN2; the disease is rheumatoid arthritis.